Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision indicator updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision v3.5.0 has been added. Revision v3.4.3 has been removed.SummaryDifference0.1%

- Check46 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded 'Gastric cancer' as a condition/topic and included a resources entry for Genetic and Rare Diseases Information Center related to gastric cancer.SummaryDifference0.2%

- Check75 days agoChange DetectedThe page shows an administrative Revision: v3.4.2 and removal of a general funding/status notice (including Revision: v3.4.1), which do not affect the study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government funding lapse notice and updated the site to revision v3.4.1 (with v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.